Pharmaceutical and Biomedical Sciences
Associate Professor

Pharmaceutical and Biomedical Sciences


Ph.D. Medicinal Chemistry, University of Florida 1987

B.S. Pharmacy, Medicinal University of South Carolina 1982

B.S. Chemistry, Erskine College 1979

Areas of Expertise

Research Areas: Relationship between PCAT performance and performance in courses requiring math skills and those requiring application of
knowledge or critical thinking

Opportunities for Collaboration:  Enhance learning and retention throughout curriculum; applying basic pharmaceutical sciences
to clinical practice

Research Interests

Dr. Beach’s research interests are in the area of the synthesis of compounds as potential treatments for neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. The current series of compounds studied in his lab (in collaboration with Dr. A.V. Terry of Georgia Health Sciences University) have a number of useful therapeutic properties including cognitive enhancement, increasing attention and decreasing/slowing the development of plaque formation in the mouse model of Alzheimer’s disease.

The elucidation of the mechanism of action of these compounds in ongoing. However, current evidence indicates that they seem to be silent desensitizers. These compounds do not cause the activation of the receptor, but cause the receptor to go into an inactive state (closed and unable to be stimulated). This desensitization leads to an up-regulation of beneficial cascades within the cell.

Selected Publications

Israel, B ; Garner, ST; Thakare, M  ; Elder, D ; Abney, T ; Azadi, P ; Beach, JW ; Price, JC ; Ahmed, H ; Capomacchia, AC. (2012). Transdermal permeation of novel n-acetyl-glucosamine/NSAIDs mutual prodrugs. Pharmaceutical Development & Technology 17(1): 48-54.  DOI: 10.3109/10837450.2010.513987

Keowkase, Roongpetch, Aboukhatwa, Marwa, Adam, Bao-Ling, Beach, J. Warren, Terry, Alvin V., Jr., Buccafussco, Jerry J., Luo, Yuan. (2010). Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans. Molecular Neurodegeneration, 2010 5(59).

J J. Buccafusco, J. W.  Beach and A. V. Terry Jr. (2009). Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development. J. Pharm.  Exper. Ther., 2009 328:364-370.

A. Sood , J. W. Beach, S. J. Webster, A. V. Terry, Jr., J. J. Buccafusco. (2007). The effects of JWB1-84-1 on memory-related task performance by amyloid Ab transgenic mice and by young and aged monkeys. J. Neuropharm. 2007 53(5): 588-600.

J. Nerurkar, J.W. Beach, M.O. Park, H.W. Jun. Solubility of (+/-)-ibuprofen and S (+/-)-ibuprofen in the presence of cosolvents and cyclodextrins. Pharmaceutical Development and Technology 2005 10(3): 413-421.

*Buccafusco JJ, Beach JW, Terry AV, Doad GS, Sood A, Arias E, Misawa H, Masai M, Fujii T, Kawashima K. Novel analogs of choline as potential neuroprotective agents. Journal of Alzheimers Disease, 2004  6(6) S85-S92 Suppl.

Why Pharmacy at UGA?

Ranked 15th out of 141 pharmacy programs in the country by US News & World Report, UGA Pharmacy is at the top of its class. Learn more below:

Start your Pharmacy Journey

Apply Today Get More Info